Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000100 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 21, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
30,000
Total Value
$1,014,417.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Sep 21, 2026 | Exercise/Conversion | 10,000 | $7.80 | $78,000.00 | 39,995 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Sep 21, 2026 | Sale | 2,900 | $92.37 | $267,869.81 | 37,095 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Sep 21, 2026 | Sale | 3,832 | $93.32 | $357,591.89 | 33,263 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Sep 21, 2026 | Sale | 601 | $94.44 | $56,760.00 | 32,662 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Sep 21, 2026 | Sale | 2,667 | $95.31 | $254,195.77 | 29,995 | Direct | โ | View Details | |
General Counsel | Employee Warrant (right to buy) | Derivative | Sep 21, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 79,996 | Direct | โ | View Details |